• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在预防中风的维生素干预试验中,评估蛋氨酸负荷前后的同型半胱氨酸水平以预测复发性中风和冠状动脉疾病。

Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.

作者信息

Pettigrew Luther C, Bang Heejung, Chambless Lloyd E, Howard Virginia J, Toole James F

机构信息

Department of Neurology, Stroke Program, Sanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY 40536-0230, United States.

出版信息

Atherosclerosis. 2008 Oct;200(2):345-9. doi: 10.1016/j.atherosclerosis.2007.11.014. Epub 2007 Dec 31.

DOI:10.1016/j.atherosclerosis.2007.11.014
PMID:18166191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3458646/
Abstract

Methionine (Met) loading increases total plasma homocysteine (tHcy) and assesses homocysteine metabolism. We tested the hypothesis that pre- or post-Met tHcy will predict recurrent stroke or coronary artery disease (CAD) in a subgroup analysis of the Vitamin Intervention for Stroke Prevention (VISP) trial. VISP subjects with non-disabling stroke underwent measurement of tHcy at baseline (fasting pre- and post-Met load) and were randomized to high/low-dose B-vitamin therapy for prevention of recurrent stroke or CAD. In the sample cohort of 2124 subjects, mean+/-S.D. tHcy levels in micromol/l were pre-Met 13.2+/-4.3, post-Met 30.4+/-9.76, and pre/post-Met Delta 17.1+/-8.3. The hazard ratio (HR) for recurrent stroke was 1.16 (p=0.026) for 1 S.D. higher pre-Met tHcy and 1.15 (p=0.054) for 1 S.D. higher post-Met tHcy. For CAD, the HR for 1 S.D. higher pre-Met tHcy was 1.27 (p=0.001) and was 1.00 (p=0.99) for post-Met tHcy. In survival analyses using pre- or post-Met as covariates, the coefficient of pre/post-Met Delta was not significant for stroke and was only marginally significant for CAD (p<0.08), but was negative. We conclude that fasting, pre-Met tHcy is as effective as post-Met tHcy or pre/post-Met Delta in predicting the risk for stroke and CAD.

摘要

蛋氨酸(Met)负荷增加可使血浆总同型半胱氨酸(tHcy)升高,并可用于评估同型半胱氨酸代谢。在预防卒中的维生素干预(VISP)试验的亚组分析中,我们检验了这样一个假设:Met负荷前或负荷后的tHcy水平能够预测复发性卒中或冠状动脉疾病(CAD)。VISP试验中患有非致残性卒中的受试者在基线时(空腹状态下Met负荷前后)测量了tHcy水平,并被随机分为高/低剂量B族维生素治疗组,以预防复发性卒中和CAD。在2124名受试者的样本队列中,以微摩尔/升为单位的平均±标准差tHcy水平在Met负荷前为13.2±4.3,负荷后为30.4±9.76,负荷前后的差值为17.1±8.3。Met负荷前tHcy水平每升高1个标准差,复发性卒中的风险比(HR)为1.16(p = 0.026);Met负荷后tHcy水平每升高1个标准差,HR为1.15(p = 0.054)。对于CAD,Met负荷前tHcy水平每升高1个标准差,HR为1.27(p = 0.001);而Met负荷后tHcy水平对应的HR为1.00(p = 0.99)。在以Met负荷前或负荷后作为协变量的生存分析中,Met负荷前后的差值系数对卒中而言无统计学意义,对CAD仅有边缘统计学意义(p < 0.08),但为负值。我们得出结论,空腹状态下Met负荷前的tHcy在预测卒中和CAD风险方面与Met负荷后的tHcy或Met负荷前后的差值同样有效。

相似文献

1
Assessment of pre- and post-methionine load homocysteine for prediction of recurrent stroke and coronary artery disease in the Vitamin Intervention for Stroke Prevention Trial.在预防中风的维生素干预试验中,评估蛋氨酸负荷前后的同型半胱氨酸水平以预测复发性中风和冠状动脉疾病。
Atherosclerosis. 2008 Oct;200(2):345-9. doi: 10.1016/j.atherosclerosis.2007.11.014. Epub 2007 Dec 31.
2
Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.降低同型半胱氨酸疗法与复发性中风、心肌梗死及死亡风险:年龄在VISP试验中的影响
Cerebrovasc Dis. 2014;37(4):263-7. doi: 10.1159/000360153. Epub 2014 Apr 15.
3
Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.新加坡中风患者亚甲基四氢叶酸还原酶多态性及维生素治疗的降同型半胱氨酸作用
Stroke. 2006 Feb;37(2):456-60. doi: 10.1161/01.STR.0000199845.27512.84. Epub 2006 Jan 5.
4
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.血浆β淀粉样蛋白、同型半胱氨酸与认知:预防中风的维生素干预(VISP)试验
Neurology. 2009 Jan 20;72(3):268-72. doi: 10.1212/01.wnl.0000339486.63862.db.
5
Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.蛋氨酸合成酶(A2756G)和蛋氨酸合成酶还原酶(A66G)基因多态性对血浆同型半胱氨酸水平的影响及其与冠状动脉疾病风险的关系。
Acta Cardiol. 2006 Feb;61(1):51-61. doi: 10.2143/AC.61.1.2005140.
6
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.在谷类面粉强化叶酸时代对冠心病患者进行的总同型半胱氨酸降低治疗。
Arterioscler Thromb Vasc Biol. 2002 Mar 1;22(3):488-91. doi: 10.1161/hq0302.105369.
7
Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.维生素B6、B12与叶酸:与血浆总同型半胱氨酸的关联及冠状动脉粥样硬化风险
J Am Coll Nutr. 1998 Oct;17(5):435-41. doi: 10.1080/07315724.1998.10718790.
8
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.冠心病患者血浆同型半胱氨酸及氧化应激与炎症标志物——维生素补充的前瞻性随机研究
Clin Chem Lab Med. 2005;43(6):628-34. doi: 10.1515/CCLM.2005.108.
9
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.血浆总同型半胱氨酸、B族维生素与冠状动脉粥样硬化风险
Arterioscler Thromb Vasc Biol. 1997 May;17(5):989-95. doi: 10.1161/01.atv.17.5.989.
10
Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects.维生素B6和血浆总同型半胱氨酸水平均可预测健康受试者的长期动脉粥样硬化血栓形成事件。
Eur Heart J. 2007 Feb;28(4):484-91. doi: 10.1093/eurheartj/ehl470. Epub 2007 Jan 31.

引用本文的文献

1
GC-MS-Based Metabolomics to Reveal the Protective Effect of Gross Saponins of Fruit against Ischemic Stroke in Rat.基于 GC-MS 的代谢组学揭示了果实总皂苷对大鼠缺血性中风的保护作用。
Molecules. 2019 Feb 22;24(4):793. doi: 10.3390/molecules24040793.
2
Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial.在预防中风的维生素干预临床试验中,全表观基因组分析确定了与复发性中风的两种新关联。
Front Genet. 2018 Sep 6;9:358. doi: 10.3389/fgene.2018.00358. eCollection 2018.
3
Effects of exercise training on stroke risk factors, homocysteine concentration, and cognitive function according the genotype in stroke patients.运动训练对脑卒中患者中风危险因素、同型半胱氨酸浓度及认知功能的影响:基于基因型的研究
J Exerc Rehabil. 2018 Apr 26;14(2):267-274. doi: 10.12965/jer.1836108.054. eCollection 2018 Apr.
4
Testing and estimation in marker-set association study using semiparametric quantile regression kernel machine.使用半参数分位数回归核机器进行标记集关联研究中的检验与估计。
Biometrics. 2016 Jun;72(2):364-71. doi: 10.1111/biom.12438. Epub 2015 Nov 17.
5
Synergism and rules of the new combination drug Yiqijiedu formulae (YQJD) on ischemic stroke based on amino acids (AAs) metabolism.基于氨基酸代谢探讨新型组合药物益气解毒方(YQJD)治疗缺血性脑卒中的协同作用及规律。
Sci Rep. 2014 Jun 3;4:5149. doi: 10.1038/srep05149.
6
Homocysteine and carotid plaque stability: a cross-sectional study in Chinese adults.同型半胱氨酸与颈动脉斑块稳定性:中国成年人的横断面研究。
PLoS One. 2014 Apr 15;9(4):e94935. doi: 10.1371/journal.pone.0094935. eCollection 2014.
7
Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk.转钴胺素 2 变体与卒中后同型半胱氨酸相关,可改变复发性卒中风险。
Neurology. 2011 Oct 18;77(16):1543-50. doi: 10.1212/WNL.0b013e318233b1f9. Epub 2011 Oct 5.

本文引用的文献

1
Homocysteine levels--before and after methionine loading--in 51 Dutch families.51个荷兰家庭中同型半胱氨酸水平(蛋氨酸负荷前后)。
Eur J Hum Genet. 2005 Jun;13(6):753-62. doi: 10.1038/sj.ejhg.5201389.
2
Subgroup analysis in clinical trials.临床试验中的亚组分析。
Med J Aust. 2004 Mar 15;180(6):289-91. doi: 10.5694/j.1326-5377.2004.tb05928.x.
3
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.降低缺血性中风患者的同型半胱氨酸水平以预防复发性中风、心肌梗死和死亡:中风预防维生素干预(VISP)随机对照试验。
JAMA. 2004 Feb 4;291(5):565-75. doi: 10.1001/jama.291.5.565.
4
Baseline data in clinical trials.临床试验中的基线数据。
Med J Aust. 2003 Jul 21;179(2):105-7. doi: 10.5694/j.1326-5377.2003.tb05447.x.
5
Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease.同型半胱氨酸的决定因素以及同型半胱氨酸在多大程度上决定冠心病风险的证据。
Pharmacol Rev. 2002 Dec;54(4):599-618. doi: 10.1124/pr.54.4.599.
6
Short-term variability in the measurement of plasma homocysteine, fasting and post-methionine loading.
Clin Biochem. 2001 Feb;34(1):49-52. doi: 10.1016/s0009-9120(00)00198-3.
7
Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design.维生素预防中风干预(VISP)试验:原理与设计
Neuroepidemiology. 2001 Feb;20(1):16-25. doi: 10.1159/000054753.
8
Subgroup analysis and other (mis)uses of baseline data in clinical trials.临床试验中基线数据的亚组分析及其他(不当)用途。
Lancet. 2000 Mar 25;355(9209):1064-9. doi: 10.1016/S0140-6736(00)02039-0.
9
Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.高同型半胱氨酸血症后快速发生血管内皮功能障碍的证明:维生素C治疗可逆转此效应。
Circulation. 1999 Mar 9;99(9):1156-60. doi: 10.1161/01.cir.99.9.1156.
10
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.血浆同型半胱氨酸作为血管疾病的危险因素。欧洲协作行动项目。
JAMA. 1997 Jun 11;277(22):1775-81. doi: 10.1001/jama.1997.03540460039030.